Article info

Download PDFPDF

Evaluation of PARP and PDL-1 as potential therapeutic targets for women with high-grade neuroendocrine carcinomas of the cervix

Authors

  1. Correspondence to Dr Michael Frumovitz, Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77057, USA; mfrumovitz{at}mdanderson.org
View Full Text

Citation

Carroll MR, Ramalingam P, Salvo G, et al
Evaluation of PARP and PDL-1 as potential therapeutic targets for women with high-grade neuroendocrine carcinomas of the cervix

Publication history

  • Received May 21, 2020
  • Revision received June 22, 2020
  • Accepted June 29, 2020
  • First published July 29, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.